Characterization and Immunological Properties of Influenza A Virus Nucleoprotein (NP): Cell-associated NP Isolated from Infected Cells or Viral NP Expressed by Vaccinia Recombinant Virus do not Confer Protection
- 1 May 1990
- journal article
- research article
- Published by Microbiology Society in Journal of General Virology
- Vol. 71 (5) , 1169-1179
- https://doi.org/10.1099/0022-1317-71-5-1169
Abstract
A nucleoprotein (NP) preparation purified from the chorioallantoic membrane of chicken eggs infected with fowl plague virus (A/FPV/Rostock/34, H7N1) yielded, in addition to the commonly known 56K protein, a 42K component that could be detected in virus particles. After testing with a series of NP-specific monoclonal antibodies it was found that some reacted with both proteins and others were bound only by the 56K protein. Among both types of NP-specific monoclonal antibodies only a limited number were bound to infected murine cells. Some antibodies bound to cells infected with a given subtype failed to react with the surface of cells infected with a different subtype. Binding was demonstrated by cellular ELISA, radioimmunoassay and immunofluorescence. The results indicate that only restricted antigenic domains of the native NP and perhaps NP fragments are exposed at the surface of infected murine cells. Additionally, the purified NP preparation was used to immunize mice in order to determine the protective capacity of cell-associated NP. In parallel, and as a relevant control, mice were immunized with a vaccinia virus recombinant containing the gene for NP prior to challenge with infectious virus. High levels of monospecific antibodies and a cytotoxic T cell activity was found in mice immunized with purified NP or infected with the vaccinia recombinant after secondary restimulation in vitro. After treatment with specific antibodies the cytotoxic cells were shown to be classical CD8+ cytotoxic T lymphocytes. Despite the elicitation of a humoral and a cellular immune response by the forms of NP employed mice were not protected from influenza virus infection.This publication has 20 references indexed in Scilit:
- The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells.The Journal of Experimental Medicine, 1984
- Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin.Proceedings of the National Academy of Sciences, 1983
- Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.Proceedings of the National Academy of Sciences, 1982
- Eggs: Conveniently packaged antibodies. Methods for purification of yolk IgGJournal of Immunological Methods, 1981
- Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions.The Journal of Experimental Medicine, 1981
- Two forms of influenza virus nucleoprotein in infected cells and virionsVirology, 1981
- A New Mouse Myeloma Cell Line that Has Lost Immunoglobulin Expression but Permits the Construction of Antibody-Secreting Hybrid Cell LinesThe Journal of Immunology, 1979
- Immunologic recognition of influenza virus-infected cellsCellular Immunology, 1977
- Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses.The Journal of Experimental Medicine, 1977
- Chemical Fixation of Enzymes to Cyanogen Halide Activated Polysaccharide CarriersEuropean Journal of Biochemistry, 1971